Brought to you by MedPage Today. 1. SERMs Still Have Value for Breast Ca Prevention. Treatment with selective estrogen receptor modulators (SERMs) led to long-term protection against breast cancer. 2. C. Diff Infection Eludes European Hospitals. Infection with Clostridium difficile – a dangerous and potentially deadly condition – appears to be substantially under-diagnosed in European hospitals. 3. Medicare Panel to Mull ...

Read more...

The other day I landed on the website of 23andMe. To my surprise, I learned that if I wanted to send the company a sample of my DNA, I’d have to swear under penalty of law neither to  collect my  sample nor mail it from New York State. That’s because New York State requires a laboratory license and direct interaction with a physician for mail order DNA testing. New York, it ...

Read more...

The need for evidence in genomic medicineAn IOM report makes recommendations that aim to ensure that progress in omics-based test development is grounded in sound scientific evidence and is reproducible, resulting in improved health care and continued public trust in research.  Another new IOM roundtable workshop report discussed the differences in evidence required for clinical use, regulatory oversight, guideline inclusion, coverage, and reimbursement of genomic ...

Read more...

Some of your relatives have had cancer. And, you’ve heard that people with a family history of the disease may be more likely to get cancer. So, should you consider genetic testing to find out if cancer runs in your family? Here’s what you need to know to make a more informed decision. Most cancer cases aren’t related to family history. Only about 5 to 10% of cancer cases are due to an ...

Read more...

1 Pages